Cyclophosphamide for lupus during pregnancy

Lupus

Volumn 14, Issue 8, 2005, Pages 593-597

  Clowse, Megan E B ^a,c   Magder, L ^b   Petri, M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Center Tower ^*  (United States)

Author keywords

Cyclophosphamide; Pregnancy; SLE

Indexed keywords

CYCLOPHOSPHAMIDE;

FETUS OUTCOME; FETUS WASTAGE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

ABORTION, SPONTANEOUS; ADULT; CYCLOPHOSPHAMIDE; FEMALE; FETAL DEATH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND;

EID: 24744454021     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2169oa     Document Type: Review

References (18)

1. Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001; 77: 157-165.
2. Kirshon B, Wasserstrum N, Willis R, Herman GE, McCabe ER. Teratogenic effects of first-trimester cyclophosphamide therapy. Obstet Gynecol 1988; 72: 462-464.
3. Enns GM, Roeder E, Chan RT et al. Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999; 86: 237-241.
4. Berry DL, Theriault RL, Holmes FA et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999; 17: 855-861.
5. Dayoan ES, Dimen LL, Boylen CT. Successful treatment of Wegener s granulomatosis during pregnancy: a case report and review of the medical literature. Chest 1998; 113: 836-838.
6. Kart Koseoglu H, Yucel AE, Kunefeci G, Ozdemir FN, Duran H. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 2001; 10: 818-820.
7. Parnham AP, Thatcher GN. Pregnancy and active Wegener granulomatosis. Aust N Z J Obstet Gynaecol 1996; 36: 361-363.
8. Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 1992; 28: 188-191.
9. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991; 34: 1538-1545.
10. Vaux KK, Kahole NC, Jones KL. Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway? Birth Defects Res Part A Clin Mol Teratol 2003; 67: 403-408.
11. Lima F, Buchanan N, Froes L, Kerslake S, Khamashta MA, Hughes GR. Pregnancy in granulomatous vasculitis. Ann Rheum Dis 1995; 54: 604-606.
12. Giannakopoulou C, Manoura A, Hatzidaki E, Korakaki E, Froudarakis G, Koumandakis E. Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 2000; 91: 95-97.
13. Ba-Thike K, Oo N. Non-Hodgkin's lymphoma in pregnancy. Asia Oceania J Obstet Gynaecol 1990; 16: 229-232.
14. Francis BM, Rogers JM, Sulik KK et al. Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity. Teratology 1990; 42: 473-482.
15. Gwyn KM, Theriault RL. Breast cancer during pregnancy. Curr Treat Options Oncol 2000; 1: 239-243.
16. Martin D, Winter SS, Gardner MO, Nicklaus P. Rhabdomyosarcoma treated with chemotherapy during the third trimester. Obstet Gynecol 1997; 89: 828-831.
17. Werth V Current treatment of cutaneous lupus erythematosus. Dermatol Online J 2001; 7: 2.
18. Varner MW, Meehan RT, Syrop CH, Strottmann MP, Goplerud CP. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol 1983; 145: 1025-1040.